Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Cytomegalovirus (CMV) infections spread through body fluids such as saliva, semen, breast milk, and urine. Signs and symptoms of the infections include, fatigue, fever, diarrhea, pneumonia, and hepatitis, shortness of breath, gastrointestinal ulceration, and bleeding.

Although no treatment for the infection caused by human papillomavirus (HPV) is available, symptoms can be treated. Most sexually active men and women suffer from HPV infections. The infections spread through oral, vaginal or anal sex. HPV can also be transmitted during birth to infant and can lead to genital or respiratory infections.

Market Dynamics

Increasing collaboration activities of major players is expected to propel growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in November 2018, GeoVax Labs Inc. announced collaboration with Virometix. The collaboration focuses on development of therapeutic vaccines for HPV infections. This collaboration will include preclinical animal testing of GeoVax’s MVA-Vectored HPV vaccines candidates in combination with Virometix synthetic HPV vaccines candidates.

Moreover, increasing regulatory approvals for novel therapies is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in November 2017, Merck received the U.S. Food and Drug Administration approval for its Prevymis (letermovir) tablets and intravenous (IV) injection for prophylaxis of CMV infections and CMV seropositive recipients.

Key features of the study:

  • This report provides in-depth analysis of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, , Allergan, Bausch Health, GlaxoSmithKline, Lee’s Pharmaceutical Holdings, Merck Sharp & Dohme, Fougera Pharmaceuticals, Clinigen Group plc., Perrigo Company plc., Roche Holding AG, Biotest AG, and Fresenius Kabi
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Application:
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Drug Type:
  • HPV Therapeutics
  • Immunomodulatory Agents
  • Interleukins
  • Cytokines
  • Chemokine
  • Others
  • Keratolytic Agents
  • TCA (Trichloroacetic Acid)
  • Bichloracetic Acid
  • Anti-neoplastic Agents
  • Sinecatechins
  • CMV Therapeutics
  • Ganciclovir/Valganciclovir
  • Foscarnet
  • Cidifovir
  • By Application
  • HPV Therapeutics Application
  • Genital warts
  • Cervical cancer
  • Epidermodysplasia Verrucifdormis
  • Others
  • CMV Therapeutics Application
  • CMV Retinitis
  • Pneumonia
  • Gastrointestinal ulcers
  • Encephalitis
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • GlaxoSmithKline*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Allergan
  • Bausch Health
  • Lee’s Pharmaceutical Holdings
  • Merck Sharp & Dohme
  • Fougera Pharmaceuticals
  • Clinigen Group plc.
  • Perrigo Company plc.
  • Roche Holding AG
  • Biotest AG
  • Fresenius Kabi
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Epidemiology
Technology Advancements
Patent Analysis
Adherence Rate
Product Switch (U.S.)
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER’S Five Forces
PEST Analysis
4. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market By Drug Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
HPV Therapeutics
Immunomodulatory Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Interleukins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Cytokines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Chemokine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Keratolytic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
TCA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Bichloracetic Acid
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Anti-neoplastic Agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Sinecatechins
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
CMV Therapeutics
Ganciclovir/ Valaganciclovir
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Foscarnet
Introduction
Market Size and Forecast , and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Cidifovir
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Application, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
HPV Therapeutics Application
Genital warts
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Cervical cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Epidermodysplasia Verrucifdormis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
CMV Therapeutics Application
CMV Retinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Pneumonia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Gastrointestinal ulcers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Encephalitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market, By Distribution Chanel, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Company Profiles
GlaxoSmithKline
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
ALLERGAN
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bausch Health
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Lee’s Pharmaceuticals Holdings
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck Sharp & Dohme
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Fougera Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Clinigen Group plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Perrigo Company plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Roche Holdings AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Fresenius Kabi
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 37 market data tables and 33 figures on “human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook